Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Trading Statement

30 Apr 2019 07:00

RNS Number : 4715X
Elementis PLC
30 April 2019
Β 

Elementis plc

AGM Trading Statement

Market conditions remain challenging, particularly in Coatings

On track to deliver further progress in 2019 led by self-help initiatives

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 March 2019.

Reflecting broader macroeconomic trends, global market conditions remain challenging, particularly in Coatings. Elementis anticipates further progress in 2019, albeit slightly below expectations. Some improvement in the demand environment and further cost efficiencies in-train are expected to result in a stronger second half performance.

The Group remains focused on delivering its plans to integrate the Talc business, transform Coatings and grow Personal Care. This strategy, supported by self-help measures focused on cost efficiency and cash delivery will provide a robust financial platform to deliver future growth and shareholder value creation.

Business performance

Β· Personal Care had a solid first quarter with strong growth in cosmetics offset by a weaker start in anti-perspirant active ingredients. Bentone HydroclayTM, our new hectorite-based ingredient focused on the skin care market, launched in the quarter and is building encouraging customer momentum.

Β 

Β· In Coatings, whilst price/mix improved, weak demand and some de-stocking, particularly in Asia, caused revenue to decline versus the strong prior year period. Early benefits of the transformation programme helped to partially mitigate the profit impact and the programme continues to progress at pace.

Β 

Β· Integration of the Talc business remains on track for completion by October 2019 with a focus on delivering $2m of identified cost synergies and new business opportunities. Against strong comparatives, the business saw robust performance across most of its industrial talc applications but weaker demand from paper and automotive markets.

Β 

Β· Energy had a steady start to the year with industry infrastructure constraints in North America anticipated to ease in H2.

Β 

Β· Chromium sales grew on the prior year period with improved pricing offsetting lower demand levels.

Β 

Commenting on the performance, CEO, Paul Waterman said,

"Whilst trading conditions in the first quarter of 2019 have proved challenging, Elementis remains focused on delivery, improving returns and deleveraging. This will be underpinned by the integration of the Talc business, delivery of self-help efficiency measures and an unrelenting focus on cash generation."

Β 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

Β 

Tulchan

Martin Robinson Tel: 020 7353 4200

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTLLFFTSVIAFIA
Date   Source Headline
18th Sep 20256:00 pmRNSTransaction in Own Shares
17th Sep 20255:48 pmRNSTransaction in Own Shares
16th Sep 20256:04 pmRNSTransaction in Own Shares
15th Sep 20255:26 pmRNSTransaction in Own Shares
12th Sep 20255:43 pmRNSTransaction in Own Shares
11th Sep 20256:17 pmRNSTransaction in Own Shares
10th Sep 20255:49 pmRNSTransaction in Own Shares
9th Sep 20256:09 pmRNSTransaction in Own Shares
8th Sep 20256:02 pmRNSTransaction in Own Shares
5th Sep 20255:46 pmRNSTransaction in Own Shares
4th Sep 20255:36 pmRNSTransaction in Own Shares
3rd Sep 20255:34 pmRNSTransaction in Own Shares
2nd Sep 20255:47 pmRNSTransaction in Own Shares
1st Sep 20255:53 pmRNSTransaction in Own Shares
1st Sep 20259:31 amRNSBlock listing Interim Review
29th Aug 20255:41 pmRNSTransaction in Own Shares
28th Aug 20255:27 pmRNSTransaction in Own Shares
27th Aug 20255:58 pmRNSTransaction in Own Shares
26th Aug 20255:37 pmRNSTransaction in Own Shares
22nd Aug 20255:58 pmRNSTransaction in Own Shares
21st Aug 20255:34 pmRNSTransaction in Own Shares
20th Aug 20255:32 pmRNSTransaction in Own Shares
19th Aug 20255:22 pmRNSTransaction in Own Shares
18th Aug 20255:36 pmRNSTransaction in Own Shares
15th Aug 20255:37 pmRNSTransaction in Own Shares
14th Aug 20255:22 pmRNSTransaction in Own Shares
13th Aug 20255:29 pmRNSTransaction in Own Shares
12th Aug 20255:49 pmRNSTransaction in Own Shares
11th Aug 20255:41 pmRNSTransaction in Own Shares
8th Aug 20255:25 pmRNSTransaction in Own Shares
7th Aug 20255:44 pmRNSTransaction in Own Shares
6th Aug 20256:22 pmRNSTransaction in Own Shares
5th Aug 20255:44 pmRNSTransaction in Own Shares
4th Aug 20255:41 pmRNSTransaction in Own Shares
1st Aug 20255:26 pmRNSTransaction in Own Shares
1st Aug 20254:19 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSHalf-year Report
30th Jul 20255:32 pmRNSTransaction in Own Shares
29th Jul 20255:45 pmRNSTransaction in Own Shares
28th Jul 20256:00 pmRNSTransaction in Own Shares
25th Jul 20256:00 pmRNSTransaction in Own Shares
24th Jul 20255:41 pmRNSTransaction in Own Shares
23rd Jul 20256:06 pmRNSTransaction in Own Shares
22nd Jul 20256:09 pmRNSTransaction in Own Shares
21st Jul 20255:39 pmRNSTransaction in Own Shares
18th Jul 20255:38 pmRNSTransaction in Own Shares
17th Jul 20255:49 pmRNSTransaction in Own Shares
16th Jul 20255:54 pmRNSTransaction in Own Shares
15th Jul 20255:29 pmRNSTransaction in Own Shares
14th Jul 20255:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.